P2RY1 and type 2 diabetes mellitus: Platelet miR-223 has been implicated in the ADP-receptor P2Y12 pathway [101], where reduced levels in patients with T2D compared to healthy controls are associated with increased activity of the receptor and enhanced platelet reactivity [102].